Innovative testing for cancer, chronic disease and wellness.

The Gluten ID test can identify individuals who are genetically susceptible to developing chronic inflammation from consuming gluten products.

The Hi-Res HER2 consultations are designed to meet the needs of oncologists and their patients with “double equivocal” breast cancer.

The Reversible Immune Disturbance (RID) panel analyzes common biomarkers associated with chronic inflammatory response syndrome (CIRS).